📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies. (2024)

First Author: Bachelez H

Attributed to: MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/jdv.19701

PubMed Identifier: 38213065

Publication URI: http://europepmc.org/abstract/MED/38213065

Type: Journal Article/Review

Volume: 38

Parent Publication: Journal of the European Academy of Dermatology and Venereology : JEADV

Issue: 7

ISSN: 0926-9959